David Sinclair (biologist)

David Andrew Sinclair ( born June 26, 1969 in Sydney, Australia) is an Australian biologist and professor of genetics, who specializes in the study of aging.

Life

Sinclair went on to St. Ives High School in Sydney. He received his doctorate with the title Summa cum laude from the University of New South Wales ( UNSW ) in biochemistry and molecular genetics. Since 2005 he is Director of the Paul F. Glenn Laboratories for the elucidation of the biological mechanisms of aging at Harvard Medical School ( HMS) in Cambridge. He is a professor in the Lowy Cancer Center in the Department of Pharmacology at UNSW and ordinary since 1999 Professor in the Department of Genetics at HMS.

Sinclair is married and has three children.

Work

Sinclair deals with the coenzyme nicotinamide adenine dinucleotide ( NAD). As a versatile information transport mechanism enables the protons and electrons within the cell from one location to another. By increasing the NAD energy metabolism is improved. Sinclair believed that the amount of NAD plays an important role in aging.

Lectures

At TEDxSydney he held in 2008, the lecture "A Cure for Aging? " and in October 2009 at the TEDMED the lecture: " Can a pill a day help keep aging away".

Awards

Company

Sinclair founded five biotechnology companies: In order to combat diseases ( Sirtris, NASDAQ: SIRT ), reproductive health ( OvaScience, NASDAQ: OVAS ), to combat type 2 diabetes ( Cohbar ), developing vaccines against malaria, chlamydia infection, tuberculosis, hypertension and cancer ( Genocea ), and anti-aging (Metro Biotech).

In 2008, Sinclair sold his company Sirtris Pharmaceuticals for $ 720 million to the pharmaceutical company GlaxoSmithKline.

Trivia

The research Sinclair was discussed in the documentary "To Age or Not to Age" (2010).